Skip to main content
. 2018 Apr 21;28(7):2636–2646. doi: 10.1093/cercor/bhy093

Table 3.

[11C]raclopride binding potential ratio in clusters

Raclopride BPR, mean (±SD)
Cluster volume (mm3)/tDCS group Condition 1 Condition 2 Relative variation, % Difference Active—Sham Group
Right caudate nucleus
 272 Baseline Stimulation + Post1 + Post2 −22.46
Active tDCS 5.78 (±0.88) 4.89 (±1.40) −15.05 (±9.47)
Sham tDCS 4.93 (±1.01) 5.23 (±1.48) 7.41 (±14.79)
 352 Baseline Post1 + Post2 −25.36
Active tDCS 5.66 (±0.83) 4.55 (±1.28) −19.05 (±9.86)
Sham tDCS 4.78 (±0.91) 5.02 (±1.39) 6.31 (±15.57)
 144 Stimulation Post1 + Post2 −20.33
Active tDCS 4.77 (±1.19) 4.18 (±1.74) −11.73 (±21.18)
Sham tDCS 4.46 (±1.49) 4.84 (±2.05) 8.60 (±15.48)
 144 Stimulation Post1 −33.82
Active tDCS 3.99 (±1.30) 3.39 (±1.43) −13.34 (±18.71)
Sham tDCS 3.35 (±1.09) 3.94 (±1.57) 20.48 (±26.03)
 360 Baseline Post2 −31.97
Active tDCS 5.64 (±0.92) 4.31 (±1.36) −23.32 (±12.03)
Sham tDCS 4.82 (±0.89) 5.16 (±1.55) 8.65 (±19.90)
 128 Stimulation Post2 −29.32
Active tDCS 5.64 (±1.47) 4.52 (±2.04) −19.02 (±25.83)
Sham tDCS 5.00 (±1.62) 5.47 (±2.45) 10.30 (±22.03)
Left putamen
 160 Stimulation Post1 + Post2 −16.49
Active tDCS 7.91 (±2.13) 6.58 (±2.00) −13.89 (±18.07)
Sham tDCS 6.81 (±2.03) 6.80 (±1.88) 2.60 (±19.96)
 192 Stimulation Post1 −13.99
Active tDCS 6.86 (±1.53) 5.78 (±1.52) −13.99 (±21.78)
Sham tDCS 6.04 (±1.39) 6.00 (±1.55) −0.00 (±18.03)
 128 Baseline Post2 −25.9
Active tDCS 4.89 (±0.94) 4.44 (±2.13) −6.95 (±25.21)
Sham tDCS 4.43 (±0.86) 5.28 (±2.10) 18.95 (±23.71)

[11C]raclopride binding potential in clusters revealed by the parametric analysis—BPR variations during and after the stimulation compared with baseline (relative variation, %). The anatomical subparts of the striatum (i.e., caudate nucleus, putamen, and nucleus accumbens) were named based on the Hammersmith maximum probability brain atlas.